🔎 Trials Near Me

Gara Jalqabaatti › Leukemia Myeloidii Hamaa › Michigan › Ann Arbor

Qorannoo klinikaalii Leukemia Myeloidii Hamaa Ann Arbor, MI keessatti

Qorannoo 17 Leukemia Myeloidii Hamaa f Ann Arbor fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · Miili 15 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · Miili 18 fagaatti
Umuriin 60 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07437950

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · Miili 15 fagaatti
  • fi 1 dabalataa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05564390

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • C S Mott Children's Hospital, Ann Arbor
Hanga umuriin 21 · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07012044

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • fi 4 dabalataa
Umuriin 40 hanga 75 · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT05334069

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · Miili 15 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · Miili 18 fagaatti
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 3
  • Trinity Health Michigan Heart - Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · Miili 15 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · Miili 18 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · Miili 15 fagaatti
  • fi 1 dabalataa
Umuriin 18 hanga 59 · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Namoota walitti qabaa jiraSadarkaa 2
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Miili 7 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · Miili 15 fagaatti
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · Miili 18 fagaatti
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Namoota walitti qabaa jiraSadarkaa 3
  • C S Mott Children's Hospital, Ann Arbor
6 Months – 21 Years · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT04293562

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 3
  • C S Mott Children's Hospital, Ann Arbor
Umuriin 1 hanga 25 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07022678

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Namoota walitti qabaa jiraSadarkaa 3
  • C.S. Mott Children's Hospital, Ann Arbor
29 Days – 21 Years · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

Namoota walitti qabaa jiraSadarkaa 3
  • University of Michigan, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT07007312

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Michigan, Ann Arbor
Umuriin hundi · Saalaa hunda · Haaromfame 06-Ado-2026 · NCT01351545

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Namoota walitti qabaa jiraSadarkaa 1
  • University of Michigan, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Wax-2026 · NCT05768932

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Namoota walitti qabaa jiraSadarkaa 1
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT05735184

Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti

Qorannoo biroo Ann Arbor keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.